C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.67 AUD
-1.76%
Market Closed
Updated:
May 15, 2024
Cyclopharm Ltd
Research & Development
|
Cyclopharm Ltd
Research & Development Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$3.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-57%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Research & Development
-AU$6.5m
|
CAGR 3-Years
-185%
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Research & Development
-AU$236k
|
CAGR 3-Years
52%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$269.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Research & Development
-AU$3.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Research & Development?
Research & Development
-3.7m
AUD
-3.7m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Research & Development amounts to -3.7m AUD.
What is Cyclopharm Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-57%
-57%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Cyclopharm Ltd have been -1% over the past three years , -3% over the past five years , and -57% over the past ten years .
You don't have any saved screeners yet
